Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.50 |
| ▸ | NOS1 | P29475 | 1/20 | 0.50 |
| ▸ | NOS2 | P35228 | 1/20 | 0.50 |
| ▸ | ARG1 | P05089 | 1/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2592624 | 0.81 | NOS1 (0.47) | NOS3NOS1NOS2 | |
| SCHEMBL7617170 | 0.81 | NOS1 (0.47) | NOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL6130509 | 0.80 | NOS1 (0.49) | NOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL7605928 | 0.80 | NOS1 (0.49) | NOS3NOS1NOS2 | |
| SCHEMBL6130546 | 0.79 | NOS1 (0.49) | NOS3NOS1NOS2ARG1ARG2 | |
| SCHEMBL7611726 | 0.79 | NOS1 (0.39) | NOS3NOS1NOS2ARG1ARG2 | |
| SCHEMBL5640481 | 0.77 | NOS3 (0.52) | NOS3NOS1NOS2ARG1ARG2 | |
| SCHEMBL20435468 | 0.77 | NOS3 (0.52) | NOS3NOS1NOS2ARG1ARG2 | |
| Maleic Acid SCHEMBL27642880 | 0.77 | NOS1 (0.43) | NOS3NOS1NOS2 | |
| Maleic Acid SCHEMBL6267172 | 0.77 | NOS1 (0.43) | NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1463495-A4 | AGENTS AND METHODS FOR TREATMENT OF CANCER | PHARMACIA CORP (US) | 2005-11-16 | — | — | EP | disclosed |
| WO-2005025620-A2 | COMBINATION THERAPY WITH INHIBITORS OF INDUCIBLE NITRIC OXIDE SYNTHASE AND ALKYLATING AGENTS | PHARMACIA CORPORATION (US) | 2005-03-24 | — | — | WO | disclosed |
| EP-1463495-A2 | AGENTS AND METHODS FOR TREATMENT OF CANCER | Pharmacia Corporation (US) | 2004-10-06 | — | — | EP | disclosed |
| EP-1265859-A2 | AMIDINO COMPOUNDS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | Pharmacia Corporation (US) | 2002-12-18 | — | — | EP | disclosed |
| EP-1265860-A1 | AMIDINO COMPOUND AND SALTS THEREOF USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | Pharmacia Corporation (US) | 2002-12-18 | — | — | EP | disclosed |
| WO-2002076395-A2 | AGENTS AND METHODS FOR TREATMENT OF CANCER | PHARMACIA CORPORATION (US) | 2002-10-03 | — | — | WO | disclosed |
| WO-2001072702-A2 | AMIDINO COMPOUNDS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | PHARMACIA CORPORATION (US) | 2001-10-04 | — | — | WO | disclosed |
| WO-2001072703-A1 | AMIDINO COMPOUND AND SALTS THEREOF USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | PHARMACIA CORPORATION (US) | 2001-10-04 | — | — | WO | disclosed |